2currently using it
$960Kbooked across customers
92seats under contract
3$960K covered
Revenue, licenses, contracts, and renewals in one compact view.
Value still under contract over the next six months.
Nearest contract decisions.
Avg. per customer
$480K
Revenue per seat
$10K
Recurring share
77%
Top-account share
73%
Next renewal
Aug 31, 2026
Every commercial line, contract period, and renewal status.
| Customer | Type | Revenue | Licenses | Coverage | Status | Notes |
|---|---|---|---|---|---|---|
Helix Biologics | License | $480K | 60 | Jan 1, 2026 – Dec 31, 2026 | Active | Freya.Register seats across the global RA org. |
Helix Biologics | Project | $220K | — | Feb 1, 2026 – Aug 31, 2026 | 40d left | Registration data migration & implementation project. |
Meridian Pharmaceuticals | License | $260K | 32 | Mar 1, 2026 – Feb 28, 2027 | Active | Freya.Register licenses for the submissions team. |